• Michelle Pacis, Annielyn Azor-Ocampo, Emily Burnett, Chutiwan Tanasapphaisal, and Bernice Coleman.
• Michelle Pacis, BSN, RN, CWOCN, Department of Wound, Ostomy and Continence, Cedars-Sinai Medical Center, Los Angeles, California. Annielyn Azor-Ocampo, MSN, RN, CWOCN, DAPWCA, Department of Wound, Ostomy and Continence, Cedars-Sinai Medical Center, Los Angeles, California. Emily Burnett, MSN, RN, CNL, CWOCN, Department of Wound, Ostomy and Continence, Cedars-Sinai Medical Center, Los Angeles, California. Chutiwan Tanasapphaisal, BSN, RN, CWOCN, Department of Wound, Ostomy and Continence, Cedars-Sinai Medical Center, Los Angeles, California. Bernice Coleman, PhD, ACNP-BC, FAHA, FAAN, Department of Nursing Research, Cedars-Sinai Medical Center, Los Angeles, California.
• J Wound Ostomy Continence Nurs. 2020 Nov 1; 47 (6): 551-557.

PurposeExtended use of N95 respirator masks is far more prevalent during the coronavirus disease 2019 (COVID-19) pandemic. As WOC nurses, we were tasked with formulating procedures for protecting the facial skin integrity of healthcare workers (HCWs) using personal protective devices when caring for patients with suspected or active COVID-19, while avoiding contamination when the masks are donned or doffed. This quality improvement project describes how we approached this project within the limited time frame available as we cared for patients with established and suspected COVID-19.Participants And SettingThis project focused on HCW use of N95 respirator masks and dressings currently available in our facility. The 4 WOC nurses acted as quality improvement project directors and as participants. The setting for our project was our facility's simulation laboratory.ApproachWe evaluated 6 topical products (an alcohol-free liquid acrylate, thin film dressing, thin hydrocolloid dressing, hydrocolloid blister care cushion, thin foam transfer dressing, and thick foam dressing) applied to skin in contact with 3 N95 respirators; all are available on our facility's formulary and all are in widespread clinical use. After the product was applied to the face and nose, the N95 respirator was donned and evaluated for fit. Participants then wore the devices for 10 hours and doffed the mask using established facility procedures. In order to evaluate for potential contamination including possible aerosolization, we applied a commercially available fluorescent lotion to simulate the presence of infectious particles. Contamination was assessed using an ultraviolet light for all dressings except for the alcohol-free liquid acrylate. We also evaluated cutaneous responses (skin integrity, irritation, comfort) during this period.OutcomesWe found that contamination of the simulated pathogen did not occur with removal of any of the protective products. No skin irritation was noted with any of the tested products after a 10-hour wear time underneath the N95 respirator masks, but mild discomfort was experienced with 3 of the dressings (thin film dressing and both hydrocolloid dressings).ConclusionBased on these experiences, we recommend application of an alcohol-free liquid acrylate film to prevent facial skin injury associated with friction from the extended use of an N95 respirator mask. We further recommend performing a fit test and user-performed seal check with the use of any topical dressing and especially those that add cushion. For the duration of the COVID-19 pandemic, we recommend use of protective dressings to maintain skin integrity and protection from coronavirus infection as HCWs continue to provide care to all of patients under their care.

29 keywords...

hide…